Clover Health is trading 4.18% down at $4.59, with no clear company-specific catalyst identified. - No company-specific announcement or event was found for October 29, 2026. - Needham’s Buy initiation and $6 price target were reported October 28 alongside the prior session’s gain; they do not establish a reason for today’s decline. - U.S. markets were lower, particularly the Nasdaq, but evidence does not show this explains Clover Health’s larger decline; volume details were unavailable.